XML 68 R40.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Determination of fair value | 12 Months Ended
--- | ---
Dec. 31, 2023
Subclassifications of assets, liabilities and equities [abstract] |
Determination of fair value | Determination of fair value The Group measures financial instruments such as certain financial investments and derivatives at fair value at each balance sheet date. Level 1: The fair value of financial instruments traded in active markets is based on quoted market prices at the end of the reporting period. The financial instruments included in the level 1 consist mainly in public financial instruments and financial instruments negotiated on active markets (i.e. stock exchanges). Level 2: The fair value of financial instruments that are not traded in active markets is determined using valuation techniques, which maximize the use of observable market data and rely as little as possible on entity-specific estimates. If all significant inputs required to fair value as an instrument are directly or indirectly observable, the instrument is included in level 2. The financial instruments classified as level 2 are composed mainly from private financial instruments and financial instruments negotiated in a secondary market. Level 3: If one or more of the significant inputs is unobservable, the instrument is included in level 3. This is the case for unlisted equity securities. Specific valuation techniques used to value financial instruments include: •Financial assets (other than derivatives) – The fair value of securities is determined by reference to their closing prices on the date of presentation of the consolidated financial statements. If there is no market price, fair value is estimated based on the present value of future cash flows discounted using the observable rates and market rates on the date of presentation. •Swap – These operations swap cash flow based on the comparison of profitability between two indexers. Thus, the agent assumes both positions – put in one indexer and call on another. •Forward – at the market quotation value, and the installments receivable or payable are fixed to a future date, adjusted to present value, based on market rates published at B3. •Futures – Foreign exchange rates, prices of shares and commodities are commitments to buy or sell a financial instrument at a future date, at a contracted price or yield and may be settled in cash or through delivery. Daily cash settlements of price movements are made for all instruments. •Options – option contracts give the purchaser the right to buy or sell the instrument at a fixed price negotiated at a future date. Those who acquire the right must pay a premium to the seller. This premium is not the price of the instrument, but only an amount paid to have the option (possibility) to buy or sell the instrument at a future date for a previously agreed price. •Others: Derivatives – the warrant liabilities issued by XPAC Corporation Corp. contain features that qualify as embedded derivatives. The fair value of Public Warrants issued in connection with the Initial Public Offering were measured based on the listed market price of such warrants. •Other financial assets and liabilities – Fair value, which is determined for disclosure purposes, is calculated based on the present value of the principal and future cash flows, discounted using the observable rates and market rates on the date the financial statements are presented. •Loans operations – Fair value is determined through the present value of expected future cash flows discounted using the observable rates and market rates on the date the financial statements are presented. •Contingent consideration – Fair value of the contingent consideration liability related to acquisitions is estimated by applying the income approach and discounting the expected future payments to selling shareholders under the terms of the purchase and sale agreements. Below are the Group financial assets and liabilities by level within the fair value hierarchy. The Group assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels:
|  | 2023
|  | Level 1 |  | Level 2 |  | Level 3 |  | Fair Value |  | Book Value
Financial Assets |  |  |  |  |  |  |  |  |  |
Financial assets at Fair value through profit or loss |  |  |  |  |  |  |  |  |  |
Securities |  | 92,628,880 |  |  | 10,653,332 |  |  | — |  |  | 103,282,212 |  |  | 103,282,212 |
Derivative financial instruments |  | 977,441 |  |  | 22,756,025 |  |  | — |  |  | 23,733,466 |  |  | 23,733,466 |
Investments in associates measured at fair value |  | — |  |  | — |  |  | 1,450,704 |  |  | 1,450,704 |  |  | 1,450,704 |
Fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |
Securities |  | 44,062,950 |  |  | — |  |  | — |  |  | 44,062,950 |  |  | 44,062,950 |
Evaluated at amortized cost |  |  |  |  |  |  |  |  |  |
Securities |  | 3,773,404 |  |  | 3,082,017 |  |  | — |  |  | 6,855,421 |  |  | 6,855,421 |
Securities purchased under agreements to resell |  | — |  |  | 13,551,224 |  |  | — |  |  | 13,551,224 |  |  | 14,888,978 |
Securities trading and intermediation |  | — |  |  | 2,932,319 |  |  | — |  |  | 2,932,319 |  |  | 2,932,319 |
Accounts receivable |  | — |  |  | 681,190 |  |  | — |  |  | 681,190 |  |  | 681,190 |
Loan operations |  | — |  |  | 20,874,930 |  |  | — |  |  | 28,551,935 |  |  | 28,551,935 |
Other financial assets |  | — |  |  | 4,208,743 |  |  | — |  |  | 4,208,743 |  |  | 4,208,743 |
Financial liabilities |  |  |  |  |  |  |  |  |  |
Fair value through profit or loss |  |  |  |  |  |  |  |  |  |
Securities |  | 19,949,021 |  |  | 474,053 |  |  | — |  |  | 20,423,074 |  |  | 20,423,074 |
Derivative financial instruments |  | 662,084 |  |  | 24,123,332 |  |  | — |  |  | 24,785,416 |  |  | 24,785,416 |
Evaluated at amortized cost |  |  |  |  |  |  |  |  |  |
Securities sold under repurchase agreements |  | — |  |  | 44,589,653 |  |  | — |  |  | 44,589,653 |  |  | 33,340,511 |
Securities trading and intermediation |  | — |  |  | 16,943,539 |  |  | — |  |  | 16,943,539 |  |  | 16,943,539 |
Financing instruments payable |  | — |  |  | 61,098,677 |  |  | — |  |  | 61,098,677 |  |  | 60,365,590 |
Borrowings |  | — |  |  | 3,174,285 |  |  | — |  |  | 3,174,285 |  |  | 2,199,422 |
Accounts payables |  | — |  |  | 948,218 |  |  | — |  |  | 948,218 |  |  | 948,218 |
Other financial liabilities |  | — |  |  | 11,659,653 |  |  | 571,723 |  |  | 12,231,376 |  |  | 12,231,376 |
| 2022
| Level 1 |  | Level 2 |  | Level 3 |  | Fair Value |  | Book Value
Financial Assets |  |  |  |  |  |  |  |  |
Financial assets at Fair value through profit or loss |  |  |  |  |  |  |  |  |
Securities | 73,022,643 |  |  | 14,490,361 |  |  | — |  |  | 87,513,004 |  |  | 87,513,004 |
Derivative financial instruments | 296,249 |  |  | 8,920,906 |  |  | — |  |  | 9,217,155 |  |  | 9,217,155 |
Investments in associates measured at fair value | — |  |  | — |  |  | 1,523,425 |  |  | 1,523,425 |  |  | 1,523,425 |
Fair value through other comprehensive income |  |  |  |  |  |  |  |  |
Securities | 34,478,668 |  |  | — |  |  | — |  |  | 34,478,668 |  |  | 34,478,668 |
Evaluated at amortized cost |  |  |  |  |  |  |  |  |
Securities | 7,579,658 |  |  | 1,695,368 |  |  | — |  |  | 9,275,026 |  |  | 9,272,103 |
Securities purchased under agreements to resell | — |  |  | 7,172,777 |  |  | — |  |  | 7,172,777 |  |  | 7,603,820 |
Securities trading and intermediation | — |  |  | 3,271,000 |  |  | — |  |  | 3,271,000 |  |  | 3,271,000 |
Accounts receivable | — |  |  | 597,887 |  |  | — |  |  | 597,887 |  |  | 597,887 |
Loan operations | — |  |  | 20,874,930 |  |  | — |  |  | 20,874,930 |  |  | 22,211,161 |
Other financial assets | — |  |  | 3,517,189 |  |  | — |  |  | 3,517,189 |  |  | 3,517,189 |
Financial liabilities |  |  |  |  |  |  |  |  |
Fair value through profit or loss |  |  |  |  |  |  |  |  |
Securities | 13,048,246 |  |  | 481,019 |  |  | — |  |  | 13,529,265 |  |  | 13,529,265 |
Derivative financial instruments | 167,874 |  |  | 8,437,535 |  |  | — |  |  | 8,605,409 |  |  | 8,605,409 |
Evaluated at amortized cost |  |  |  |  |  |  |  |  |
Securities sold under repurchase agreements | — |  |  | 31,370,050 |  |  | — |  |  | 31,370,050 |  |  | 31,790,091 |
Securities trading and intermediation | — |  |  | 16,062,697 |  |  | — |  |  | 16,062,697 |  |  | 16,062,697 |
Financing instruments payable | — |  |  | 43,669,798 |  |  | — |  |  | 43,669,798 |  |  | 43,683,629 |
Borrowings | — |  |  | 1,814,714 |  |  | — |  |  | 1,814,714 |  |  | 1,865,880 |
Accounts payables | — |  |  | 617,394 |  |  | — |  |  | 617,394 |  |  | 617,394 |
Other financial liabilities | — |  |  | 10,987,283 |  |  | 566,930 |  |  | 11,554,213 |  |  | 11,554,213 |
As of December 31, 2023 and 2022 the total contingent consideration liability is reported at fair value and is dependent on the profitability of the acquired associate and businesses. The total contingent consideration is classified within Level 3 of the fair value hierarchy. The contingent consideration liability represents the maximum amount payable under the purchase and sale agreements discounted using an appropriate rate, which includes the Brazilian risk free rate. Changes in an average discount rate of 10.03% by 100 bps would increase/decrease the fair value of contingent consideration liability by R$3,915. The investments held through our investees which are considered to be venture capital investments are classified as Level 3 of the fair value hierarchy. The inputs used by the Group are derived for discounted rates for these investments using a capital asset model to calculate a pre-tax rate that reflects current market assessments of the time value of money and the risk specific to the asset. Change in the discount rate by 100 bps would increase/decrease the fair value by R$14,507. Transfers into and out of fair value hierarchy levels are analyzed at the end of each consolidated financial statement. As of December 31, 2023, the Group had no transfers between Level 2 and Level 3.

X
- Definition The entire disclosure for fair value measurement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2023-01-01 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS13_g91-99_TI -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfFairValueMeasurementExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration